MNPR profile · all as-reported value updates
Monopar Therapeutics (MNPR) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2021 | 7,317,401 | -7,317,401 | -14,634,802 | -200.00% | revised comparative figure | 0001654954-22-003701 0001654954-23-003384 | 2 filed observations examined for this concept and period. |